Request for Nominations for Voting Members on a Public Advisory Committee; Science Board to the Food and Drug Administration, 64736-64737 [2010-26400]

Agencies

• Food and Drug Administration
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 75, Number 202 (Wednesday, October 20, 2010)]
[Notices]
[Pages 64736-64737]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-26400]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]


Request for Nominations for Voting Members on a Public Advisory 
Committee; Science Board to the Food and Drug Administration

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for voting members to serve on the Science Board to FDA, 
Office of the Commissioner, Office of Chief Scientist.
    FDA has a special interest in ensuring that women, minority groups, 
and individuals with disabilities are adequately represented on 
advisory

[[Page 64737]]

committees and, therefore, encourages nominations of qualified 
candidates from these groups.

DATES: Nominations received by November 19, 2010, will be given first 
consideration for membership on the Science Board. Nominations received 
after November 19, 2010, will be considered for nomination to the 
committee should nominees still be needed.

ADDRESSES: All nominations for membership should be sent electronically 
to CV@FDA.HHS.GOV, or by mail to Advisory Committee Oversight and 
Management Staff, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103, Silver 
Spring, MD 20993-0002. Information about becoming a member on an FDA 
advisory committee can also be obtained by visiting FDA's Web site at 
https://www.fda.gov/oc/advisory/default.htm.

FOR FURTHER INFORMATION CONTACT: Regarding all nomination questions for 
membership: Donna L. Mentch, Office of the Commissioner, Food and Drug 
Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 4203, Silver 
Spring, MD 20993-0002, 301-796-8523, FAX: 301-847-8617, 
donna.mentch@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: FDA is requesting nominations for voting 
members on the Science Board to FDA.

I. General Function of the Committee

    The Science Board shall provide advice primarily to the 
Commissioner of FDA (the Commissioner) and other appropriate officials 
on specific complex and technical issues as well as emerging issues 
within the scientific community. Additionally, the Science Board will 
provide advice to the Agency on keeping pace with technical and 
scientific evolutions in the fields of regulatory science, on 
formulating an appropriate research agenda, and on upgrading its 
scientific and research facilities to keep pace with these changes. It 
will also provide the means for critical review of Agency sponsored 
intramural and extramural scientific research programs.

II. Criteria for Voting Members

    FDA is requesting nominations of voting members with appropriate 
expertise in the following fields of food safety, nutrition, chemistry, 
pharmacology, toxicology, clinical research, epidemiology, product 
safety, product manufacturing sciences and quality or other scientific 
areas relevant to FDA regulated products such as systems biology, 
bioinformatics, wireless health care devices, nanotechnology, and 
combination products. Members shall be chosen from academia and 
industry. The Science Board may include one technically qualified 
member, selected by the Commissioner or designee, who is identified 
with consumer interests and is recommended by either a consortium of 
consumer-oriented organizations or other interested persons. The 
Science Board may also include technically qualified Federal members.

III. Nomination Procedures

    Any interested person may nominate one or more qualified persons 
for membership on the Science Board. Self-nominations are also 
accepted. Nominations must include a current, complete resume or 
curriculum vitae for each nominee, current business and/or home 
address, telephone number, and email address if available. Nominations 
must specify the advisory committee for which the nominee is 
recommended. Nominations must also acknowledge that the nominee is 
aware of the nomination, unless self-nominated. FDA will ask potential 
candidates to provide detailed information concerning such matters as 
financial holdings, employment, and research grants and/or contracts.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14 relating to advisory committees.

    Dated: October 15, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-26400 Filed 10-19-10; 8:45 am]
BILLING CODE 4160-01-P